The present invention provides novel pharmaceutical compositions comprising a human glucagon-like peptide-1 (GLP-1)-receptor modulator as an active ingredient in a sustained release formulation.

 
Web www.patentalert.com

< Methods of treating diabetes

> Administering hypocretin to obese individuals

> Spectroscopic catheter system with widely tunable source and method of operation
~ 00520